Blood Cancer Research

Blood Cancer Research

Deep molecular profiling of blood cancers

Archer® Blood Cancer research tests detect various driver mutations in hematologic malignancies, such as myeloid and lymphoid diseases, by targeted next-generation sequencing (NGS).

This approach combines FusionPlex® and VariantPlex® panels to characterize gene fusions, point mutations, copy number variations (CNVs) and other variant types from a single sample.

Key Features

Unified
Workflow

All Archer panels are powered by Anchored Multiplex PCR (AMP™) chemistry and follow the same workflow for maximum efficiency

Comprehensive Tumor
Profiling

Get the most information from your sample - fusions, CNVs, SNVs, indels and expression levels.

Complex Variant
Detection

Coverage combined with powerful bioinformatics enable variant detection of traditionally difficult regions like CEBPA & FLT3

Confident Variant
Calling

Powerful bioinformatics combined with orthogonal variant verification.

RNA Input
Input
Reads
Genes
RNA
1.5M
81
RNA
1.5M
87
RNA
2M
125
RNA
1.5M
84
RNA
4.5M
199
DNA Input
DNA
Reads
Genes